Clear Investment Research’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-600
Closed -$57.1K 157
2025
Q3
$57.1K Hold
600
0.08% 114
2025
Q2
$52.3K Hold
600
0.07% 110
2025
Q1
$53.9K Hold
600
0.07% 104
2024
Q4
$47.9K Hold
600
0.06% 107
2024
Q3
$54K Hold
600
0.07% 101
2024
Q2
$47.2K Hold
600
0.06% 101
2024
Q1
$52.3K Hold
600
0.07% 99
2023
Q4
$47K Hold
600
0.07% 109
2023
Q3
$47K Hold
600
0.08% 92
2023
Q2
$52.9K Hold
600
0.09% 86
2023
Q1
$48.4K Hold
600
0.08% 83
2022
Q4
$47K Hold
600
0.09% 80
2022
Q3
$48K Buy
+600
New +$53.9K 0.1% 77
2022
Q2
Sell
-600
Closed -$67K 140
2022
Q1
$67K Hold
600
0.13% 73
2021
Q4
$62K Hold
600
0.1% 75
2021
Q3
$75K Hold
600
0.12% 71
2021
Q2
$74K Buy
+600
New +$75.3K 0.12% 72
2019
Q4
Sell
-18
Closed -$2K 263
2019
Q3
$2K Hold
18
﹤0.01% 117
2019
Q2
$2K Hold
18
﹤0.01% 116
2019
Q1
$2K Hold
18
﹤0.01% 111
2018
Q4
$2K Hold
18
﹤0.01% 102
2018
Q3
$2K Buy
+18
New +$1.66K ﹤0.01% 115

Other funds holding MDT

Clear Investment Research's MDT Position: Q4 2025 in Review

Clear Investment Research sold out of Medtronic (MDT) in Q4 2025, closing a stake of 600 shares — an estimated $57.1K sold.

Clear Investment Research first reported a position in MDT in Q3 2018 and held it in 22 quarters. The position peaked at $75K in Q3 2021. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Clear Investment Research reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Clear Investment Research sold 600 Medtronic shares in Q4 2025, an estimated $57.1K.
  • Clear Investment Research first reported a position in Medtronic in Q3 2018 and held it in 22 quarters.
  • Clear Investment Research's Medtronic position peaked at $75K in Q3 2021.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Clear Investment Research's 13F filing for Q4 2025, filed 9 Feb 2026.